Haffkine Ajintha Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 22-10-2024
- Paid Up Capital ₹ 1.77 M
as on 22-10-2024
- Company Age 47 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.01 Cr
as on 22-10-2024
- Revenue 213.98%
(FY 2023)
- Profit 92.32%
(FY 2023)
- Ebitda 89.41%
(FY 2023)
- Net Worth -0.63%
(FY 2023)
- Total Assets 46.19%
(FY 2023)
About Haffkine Ajintha Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.77 M.
The company has closed loans amounting to ₹7.01 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ravindra Bapat, Subhash Shankarwar, and Madhavi Chaware serve as directors at the Company.
- CIN/LLPIN
U24239MH1977SGC019615
- Company No.
019615
- Company Classification
Public Limited State Government Company
- Incorporation Date
22 Apr 1977
- Date of AGM
29 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Haffkine Ajintha Pharmaceuticals Limited offer?
Haffkine Ajintha Pharmaceuticals Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Common Disease Medicines, Injectable Products, Tetanus Vaccine, Pharmaceutical Medicine, Antihistamines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Anti Venom Injection.
Who are the key members and board of directors at Haffkine Ajintha Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhavi Chaware  | Managing Director | 08-Feb-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Bapat | Director | 28-Dec-1999 | Current |
| Subhash Shankarwar | Nominee Director | 26-Mar-2015 | Current |
Financial Performance and Corporate Structure Insights of Haffkine Ajintha Pharmaceuticals.
Haffkine Ajintha Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 213.98% increase. The company also saw a substantial improvement in profitability, with a 92.32% increase in profit. The company's net worth dipped by a decrease of 0.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Haffkine Ajintha Pharmaceuticals?
In 2023, Haffkine Ajintha Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The United Western Bank Ltd Creation Date: 05 Jan 1998 | ₹1.50 Cr | Satisfied |
The United Western Bank Ltd Creation Date: 01 Oct 1991 | ₹3.00 M | Satisfied |
The United Western Bank Ltd Creation Date: 31 Jul 1990 | ₹2.30 M | Satisfied |
How Many Employees Work at Haffkine Ajintha Pharmaceuticals?
Unlock and access historical data on people associated with Haffkine Ajintha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Haffkine Ajintha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haffkine Ajintha Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
